Strategy2 Health System M&A Deals Disrupting Their Markets: Will They Fail?
The Wisconsin and Oregon healthcare markets have two merger deals that could completely disrupt their competitive markets if they go...
TelehealthFTC, Surescripts Settle Illegal Monopoly Complaint
The settlement comes after a federal court determined that Surescripts holds a 95% 'supershare' for e-prescribing services.
StrategyFTC Withdraws 2 Healthcare Antitrust Policy Statements
The decision 'is the best course of action for promoting fair competition in healthcare markets,' according to the FTC.
StrategyDOJ, FTC Propose Updated Merger Review Requirements
The changes could impact M&A transactions in healthcare and would require more information regarding proposed transactions.
StrategyFTC Opposes North Carolina Bill, Says It Will Shield Health System from Antitrust Enforcement
'The FTC is concerned about the increasing use of state legislation to exempt hospital consolidation that harms patients and workers...
PharmaIndivior, 42 AGs Reach $102M Suboxone Antitrust Settlement
The AGs had claimed that Invidior used 'product hopping' to block competition from generics for its opioid treatment drug.
PharmaA More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
The suit marks the first time since 2009 that the FTC has tried to block a drug company merger.
Human ResourcesUnions Ask DOJ to Investigate UPMC's 'Anticompetitive Tsunami'
SEIU, SOC accuse PA's largest health system of widespread abuses of market power.
StrategyFlagler Health+ and UF Health Reach Definitive Agreement
The deal, which would integrate Flagler Health+ into UF Health, is expected to be completed by the end of September.
TechnologyFTC RFI Wants Comments on Cloud Competition, Security
The public will have until May 22 to submit comments, which will be posted to Regulations.gov.
StrategyDOJ Strikes 'Outdated' Policies That Tamp Healthcare Competition
Justice officials note that the withdrawn guidance hasn't kept pace with the rapidly changing healthcare landscape.
PharmaCA AG Sues Insulin Makers, PBMs for Price Gouging
Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts, and OptumRx are accused of overcharging patients.